Experimental evolution of an oncolytic vesicular stomatitis virus with increased selectivity for p53-deficient cells.

Experimental evolution has been used for various biotechnological applications including protein and microbial cell engineering, but less commonly in the field of oncolytic virotherapy. Here, we sought to adapt a rapidly evolving RNA virus to cells deficient for the tumor suppressor gene p53, a hall... View More